Cardiac prosthetic devices market seen topping $15.5 billion by 2030

The cardiac prosthetic devices market is projected to grow from $9.09 billion in 2025 to $15.57 billion by 2030, driven by rising cardiovascular disease, more heart surgeries and wider use of minimally invasive treatments. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Cardiac prosthetic devices are used to support or replace heart function, making them central to care for heart failure and structural heart disease. - Rising demand signals more patients needing advanced treatment as cardiovascular disease cases increase worldwide. - The market’s growth also points to broader adoption of minimally invasive procedures and transcatheter device applications.

What happened: - The Business Research Company published its Cardiac Prosthetic Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the global cardiac prosthetic devices market at $9.09 billion in 2025 and projects $10.13 billion in 2026. - The market is forecast to reach $15.57 billion by 2030. - The report cites a 11.4% CAGR for the 2025-2026 jump and an 11.3% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also released a free sample and a full report online: More information and the full report.

The details: - Historical growth is tied to more cardiovascular disease, more heart valve disorders, more cardiac surgeries, wider availability of cardiac care centers and better clinical outcomes for prosthetic heart devices. - Forecast growth is linked to an aging population, stronger demand for minimally invasive cardiac treatments, more heart failure cases, better access to advanced cardiac care in emerging markets and more focus on early intervention in structural heart disease. - Key trends include broader use of minimally invasive prosthetic procedures, higher demand for advanced heart valve replacements, expanded use of cardiac prosthetics in heart failure care, growth in transcatheter cardiac device applications and greater focus on device durability and patient outcomes. - The report defines cardiac prosthetic devices as specialized medical tools designed to support or substitute the heart’s function or its components. - The devices are used to treat heart failure and structural heart abnormalities and can improve quality of life and clinical outcomes. - The British Heart Foundation said in January 2024 that about 7.6 million people in the UK live with heart and circulatory diseases. - The British Heart Foundation said those diseases account for about 27% of all deaths in the UK, or more than 170,000 deaths a year.

Between the lines: - The market outlook suggests demand is shifting from broad cardiac care toward more device-intensive and procedure-specific treatment. - The regional split points to mature demand in North America and faster expansion where cardiac care infrastructure is still developing. - The report’s emphasis on early intervention and minimally invasive care reflects a larger industry push to treat patients sooner and reduce surgical burden.

What's next: - The market is expected to keep expanding as aging populations and cardiovascular disease rates rise. - Growth will likely depend on how quickly hospitals and providers adopt minimally invasive and transcatheter therapies. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables.

The bottom line: - Cardiac prosthetic devices are moving from a niche specialty segment toward a larger, faster-growing part of global cardiovascular care.